New Zealand Consumer Finance Stock News

Why Mainfreight’s latest earnings and cash distribution matter for investors Mainfreight (NZSE:MFT) has drawn fresh attention after releasing full year results to 31 March 2026, with higher sales alongside lower net income, and confirming a final cash distribution to shareholders. See our latest analysis for Mainfreight. The stock’s 1 month share price return of 6.86% contrasts with a year to date share price return that is down 7.82%, while the 1 year total shareholder return is down 7.48%...

Shareholders appeared to be happy with Third Age Health Services Limited's ( NZSE:TAH ) solid earnings report last...

It looks like Napier Port Holdings Limited ( NZSE:NPH ) is about to go ex-dividend in the next 4 days. The ex-dividend...

Promisia Healthcare Limited's ( NZSE:PHL ) stock was strong after they recently reported robust earnings. However, we...

Even though Trade Window Holdings Limited ( NZSE:TWL ) has fallen by 10.0% over the past week , insiders who sold...

EBOS Group (NZSE:EBO) is back in focus after analysts maintained a Buy stance on the stock while the company reported higher quarterly revenue and net profit compared with the same period a year earlier. See our latest analysis for EBOS Group. The recent analyst support and quarterly results come after a tough run for investors, with the share price down 29.1% year to date and the 1 year total shareholder return declining 46.2%. This suggests sentiment is still rebuilding despite the latest...

Global markets have recently been buoyed by optimism surrounding a potential U.S.-Iran peace agreement, which has driven several major U.S. stock indexes to record highs, supported by falling oil prices and enthusiasm for AI-linked stocks. In this context of heightened investor sentiment, penny stocks continue to capture attention as they offer an intriguing mix of affordability and growth potential. Despite their name suggesting a bygone era, penny stocks can still provide significant...

Earnings and dividend update for Fisher & Paykel Healthcare Fisher & Paykel Healthcare (NZSE:FPH) has released its full year results to 31 March 2026 alongside a dividend update, giving investors detail on both recent profitability and upcoming cash returns. The company reported sales of NZ$2,308.4m and net income of NZ$468.5m for the year, with basic earnings per share from continuing operations of NZ$0.798 and diluted earnings per share of NZ$0.793. Alongside earnings, Fisher & Paykel...

Why Goodman Property Trust’s latest earnings matter for investors Goodman Property Trust (NZSE:GNZ) just released full year results to 31 March 2026, with sales of NZ$223.1 million compared with NZ$277.9 million and net income of NZ$248 million versus NZ$109.6 million previously. See our latest analysis for Goodman Property Trust. The latest earnings release appears to sit alongside gradually improving momentum, with a 7 day share price return of 3.59% and a 90 day share price return of 4.12%...

Global markets have been buoyed by hopes for a U.S.-Iran peace agreement, with major indices like the Nasdaq Composite and S&P 500 reaching record highs, driven in part by optimism around AI-linked stocks. Amid these developments, investors are increasingly looking beyond established giants to explore opportunities in smaller or newer companies. Penny stocks, despite their somewhat antiquated name, remain a relevant investment area offering potential for significant returns when backed by...

A lackluster earnings announcement from Turners Automotive Group Limited ( NZSE:TRA ) last week didn't sink the stock...

ikeGPS Group Limited ( NZSE:IKE ) last week reported its latest annual results, which makes it a good time for...

Fisher & Paykel Healthcare recently reported full-year results to March 31, 2026, with sales rising to NZ$2,308.4 million and net income reaching NZ$468.5 million, alongside basic earnings per share of NZ$0.798. The company also declared a six‑month dividend of NZ$0.38823529 per share, highlighting a continued focus on returning cash to shareholders as earnings grow. We’ll now examine how this stronger full-year profitability, alongside the increased dividend, shapes Fisher & Paykel...

ikeGPS Group (NZSE:IKE) has posted its FY 2026 first half numbers with revenue of NZ$12.8 million and a loss of NZ$4.4 million, equivalent to EPS of NZ$0.03. The company has seen revenue move from NZ$12.2 million in the first half of FY 2025 to NZ$12.8 million in the first half of FY 2026, while losses shifted from NZ$7.1 million to NZ$4.4 million over the same periods, setting up a results season where investors are watching how quickly the loss profile could narrow. With the stock trading...

Green Cross Health (NZSE:GXH) has kicked off FY 2026 with first half revenue of NZ$264.4 million and basic EPS of NZ$0.05, set against trailing 12 month revenue of NZ$546.0 million and EPS of NZ$0.1419 that reflects 27.7% year on year earnings growth and a net profit margin of 3.7%. Over the past two reported half years, revenue has moved from NZ$259.9 million in 1H FY 2025 to NZ$263.9 million in 2H FY 2025 and now NZ$264.4 million in 1H FY 2026, while basic EPS has shifted from NZ$0.0393 to...

Mainfreight (NZSE:MFT) has opened FY 2026 with first half revenue of NZ$2.6b and basic EPS of NZ$0.93, setting the tone for how its freight and logistics operations are translating into earnings power. The company has seen revenue move from NZ$2.6b in 1H FY 2025 to NZ$2.7b in 2H FY 2025 and NZ$2.6b in 1H FY 2026, while EPS shifted from NZ$1.14 to NZ$1.59 over FY 2025 halves before landing at NZ$0.93 in the latest period. This gives investors a clearer view of how volumes and pricing are...

Readers hoping to buy My Food Bag Group Limited ( NZSE:MFB ) for its dividend will need to make their move shortly, as...

Following the solid earnings report from AFT Pharmaceuticals Limited ( NZSE:AFT ), the market responded by bidding up...

Why Ryman Healthcare’s latest earnings are back in focus Ryman Healthcare (NZSE:RYM) has moved back onto investor watchlists after releasing full year results that combined higher revenue, a smaller reported net loss and positive free cash flow for the first time in over a decade. See our latest analysis for Ryman Healthcare. The NZ$2.28 share price has seen a sharp 7 day share price return of 11.22% and a 30 day share price return of 5.07%. However, this sits against a year to date share...

It's been a pretty great week for Fisher & Paykel Healthcare Corporation Limited ( NZSE:FPH ) shareholders, with its...

Shareholders in Infratil Limited ( NZSE:IFT ) may be thrilled to learn that the analysts have just delivered a major...

Ryman Healthcare (NZSE:RYM) has reported its FY 2026 first half with revenue of NZ$413.5 million and a basic EPS loss of NZ$0.04, while trailing 12 month figures show revenue of NZ$855.6 million and a basic EPS loss of NZ$0.17 as the company works through a period of weaker profitability. The company has seen revenue move from NZ$365.2 million in the first half of FY 2025 to NZ$394.0 million in the second half and now NZ$413.5 million in the first half of FY 2026, with EPS swinging from a...

New Zealand King Salmon Investments Limited ( NZSE:NZK ), might not be a large cap stock, but it led the NZSE gainers...

Fisher & Paykel Healthcare (NZSE:FPH) has opened FY 2026 with first half revenue of NZ$1.1b and basic EPS of NZ$0.36, setting the tone for investors focused on how its profit engine is tracking. The company has seen revenue move from NZ$951.2m and EPS of NZ$0.26 in the first half of FY 2025 to NZ$1.1b and EPS of NZ$0.36 in the latest half, with trailing 12 month EPS reaching NZ$0.80 alongside a net profit margin of 20.2% versus 9.4% a year earlier. This puts profitability firmly in focus as...